Interview: Aussie biotech on the cusp of big breakthrough
FEAR & GREED | Business News · Fear and Greed
March 8, 202211m 58s
Audio is streamed directly from the publisher (p.podderapp.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.
Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming.
Find out more: https://fearandgreed.com.au/
See omnystudio.com/listener for privacy information.